2021 American Transplant Congress » Kidney Immunosuppression: Novel Regimens and Drug Minimization

Date & Time:
None. Available on demand

Location: Virtual

Session Type: Poster Abstract

Meeting: 2021 American Transplant Congress

A Comparison of Belatacept Conversion Regimens from Calcineurin Inhibitor-Based Immunosuppression

E. Huang, A. Vo, A. Peng, R. Najjar, S. Sethi, S. Jordan
Association of Belatacept Conversion on Patient and Allograft Survival in Kidney Transplant Recipients with Congestive Heart Failure

H. Mogallapalli
Avoiding Tacrolimus Under- and Overexposure with a Dosing Algorithm for Renal Transplant Recipients: A Single Arm Prospective Intervention Trial

M. I. Francke¹, L. M. Andrews², H. L. Le², J. van de Wetering¹, M. C. Clahsen-van Groningen³, T. van Gelder⁴, R. H. van Schaik⁵, B. van der Holt⁶, B. C. de Winter², D. A. Hesselink¹
Belatacept Conversion in Elderly Renal Transplant Recipients

M. Durst¹, D. Felix¹, M. Jorgenson¹, J. Descourouez¹, B. C. Astor², D. Mandelbrot²
Belatacept Utilization During the Covid-19 Pandemic in the United States

M. MacConmara, A. Shubin, D. Wojciechowski, L. de Gregorio, J. Shah, P. Vagefi, C. S. Hwang
Calcineurin Inhibitor Dose and Selection, Not Antiproliferatives or Steroids, Influence Development of DSA One Year Post-kidney Transplant

M. Henderson¹, G. Morris², L. Awdishu¹, K. Fabbri¹, M. Shah³, A. Khan³, J. Kerr¹
Early Conversion to Belatacept-based Therapy Improves Graft Function in Renal Transplant Patients

N. Huang¹, C. J. Yang², I. Movileanu¹, R. H. Dvorai³, K. M. Ecal¹, R. F. Saidi¹, A. N. Ayla Senay¹, B. Gallay⁴, M. J. Hanlon¹, S. Narsipur⁴, M. R. Laftavi¹, R. Shahbazov¹
Effect of Early Steroid Withdrawal on Posttransplant Diabetes Mellitus Among Kidney Transplant Recipients Differs by Recipient Age

J. Ahn¹, S. Bae¹, M. Schnitzler², G. Hess³, K. Lentine², D. Segev¹, M. McAdams-DeMarco¹
Evaluation of Conversion to Extended-Release Tacrolimus in Abdominal Organ and Thoracic Transplant Recipients

A. Diamond¹, N. Agarwal², A. Younas², N. Sifontis², J. Au¹, C. Ruggia-Check¹
Evaluation of Empiric Extended-Release Tacrolimus Dosing in Adult Kidney Transplant Recipients

C. Patel, S. Lee, D. M. Salerno, N. W. Lange, J. Hedvat
Evaluation of Rituximab-abbs in Renal Transplant: A Case Series

A. Dao¹, B. Jimenez², A. Reyad¹, J. Guiteau¹, M. Madhrira³, N. Umezurike¹, S. Patel¹, S. Allam³
Kidney Transplant Outcomes Stratified by Age with a Calcineurin and Steroid Free Regimen

R. Scalzo¹, M. Harris¹, J. Morris², J. Byrns¹
Kidney Transplant Outcomes Stratified by Race with a Calcineurin and Steroid Free Regimen

R. E. Scalzo, M. T. Harris, J. D. Morris, J. S. Byrns
Modeling of Alternative Weight-Based Dosing Strategies of LCP-Tacrolimus in De Novo Kidney Transplant Patients

J. D. Momper¹, S. J. Patel², M. A. Moten², D. R. Stevens², U. Meier-Kriesche²
Obesity Impacts Acute Rejection but Not Allograft Function Improvement in the Setting of Belatacept Conversion

D. Pierce, J. Benken, P. West-Thielke, I. Tzvetanov, E. Benedetti, A. Lichvar
Sharp Anti-HLA Antibody Development Due to Concomitant Graft Nephrectomy and Immunosuppression Withdrawal After Early Graft Loss

R. Valero¹, A. Aguilera¹, E. Rodrigo¹, D. San Segundo², M. Lopez-Hoyos², J. Ruiz¹
Tacrolimus Variability Score Outperforms Coefficient of Variation in Predicting Clinical Outcomes of Living Kidney Transplantation

S. Yin, T. Song, Q. Zhong, T. Lin
Tolerability of De Novo and Conversion Belatacept Regimens in Kidney Transplantation

T. Le¹, J. Shoji², J. Phillips¹, D. Quan¹
Tolerability of Mycophenolate Mofetil in Elderly Kidney Transplant Recipients: A Retrospective Cohort Study

S. Witek¹, G. Malat², D. Sawinski², C. Sammons², C. LaFratte¹, A. Forte¹, R. Samudralwar¹, S. Lyle¹, J. Rashid¹, J. Trofe-Clark²

« View all sessions from the 2021 American Transplant Congress